read next
How Long Does IVF Actually Take? A Realistic Timeline from First Appointment to Transfer
You got the results. Now you're staring at a page full of acronyms — AMH, FSH, E2, AFC — with numbers next to them and no idea what any of it means for your chances of getting pregnant.
This guide translates every major fertility bloodwork result into plain language. We've sourced the reference ranges from current clinical guidelines and peer-reviewed research, and we've tried to give you the honest, nuanced picture — not the oversimplified "good vs. bad" framing that leaves most patients more confused than when they started.
One thing worth stating upfront: no single number tells your whole fertility story. Your RE looks at all of these results together, alongside your age, medical history, and symptoms. What we can do is help you understand what each one measures and why it matters.
"A single number is a data point. Your fertility story is written in all of them together."
The four markers
What your first panel typically measures
Most initial fertility bloodwork panels — usually drawn on day 2 or 3 of your menstrual cycle — measure four things. Here's what each one is actually assessing.
AMH
Anti-Müllerian Hormone
The most reliable single marker of ovarian reserve — how many eggs you have remaining. Produced by cells surrounding small developing follicles, AMH stays stable throughout your menstrual cycle, which makes it a consistent baseline measure regardless of when it's drawn.
AMH tells you about quantity, not quality. A lower AMH doesn't mean your eggs are poor quality — it means there are fewer of them available.
FSH
Follicle-Stimulating Hormone
FSH is the hormone your pituitary gland releases to tell your ovaries to develop follicles each month. When ovarian reserve is low, your brain works harder to stimulate the ovaries — producing more FSH. A higher FSH often signals lower reserve.
FSH must be interpreted alongside estradiol — an elevated estradiol can artificially suppress FSH into a "normal" range, masking a reserve issue.
Estradiol (E2)
Day 3 Baseline Estrogen
A form of estrogen that should be low at baseline (day 2–3 of your cycle). It's checked primarily as a quality control on your FSH result — an elevated baseline E2 can suppress FSH into a normal-looking range even when reserve is diminished.
An elevated baseline E2 may also indicate a residual cyst from the previous cycle, which may cause your RE to delay starting a cycle.
AFC
Antral Follicle Count
Measured by transvaginal ultrasound, not bloodwork — but typically done at the same baseline visit. Your RE counts small fluid-filled follicles (2–9mm) visible in both ovaries. Each represents an egg that could mature with stimulation medication.
AFC is the strongest predictor of how your ovaries will respond to IVF medications — more follicles generally means more eggs retrieved.
AMH explained
What your AMH number actually means
AMH is typically reported in nanograms per milliliter (ng/mL). Reference ranges vary slightly between labs, so always read your result against your lab's own reference range first. That said, here is a broadly accepted clinical framework based on current fertility research.
| AMH level | General interpretation | What it often means for treatment |
|---|---|---|
| Above 4.0 ng/mL | High — possible PCOS | Many follicles present. May indicate PCOS if combined with irregular cycles. High responder to stimulation — OHSS risk needs monitoring. |
| 1.0 – 4.0 ng/mL | Normal range | Good ovarian reserve for the age. Expected response to stimulation medications. Strong IVF prognosis in most age groups. |
| 0.5 – 1.0 ng/mL | Low-normal / diminished | Reduced reserve. Fewer eggs available per cycle. IVF still often viable — protocol and dose will be adjusted accordingly. |
| Below 0.5 ng/mL | Very low / DOR | Significantly diminished ovarian reserve. Requires individualized protocol. IVF with own eggs may still be possible depending on age and AFC. |
"AMH is the best single marker we have for ovarian reserve — but it's a measure of quantity, not quality. Low AMH in a 30-year-old is a very different clinical picture than the same number in someone at 42."
The key nuance most patients miss: AMH levels are meaningfully affected by age. In the early 30s, many patients see values around 1.5–3 ng/mL. In the mid-to-late 30s, AMH commonly trends lower, often near or below ~1.5 ng/mL. In the 40s, values commonly decline further and may fall below 1 ng/mL. So a result that appears "low" on a standard chart may still be age-appropriate for you.
And critically: low AMH levels (below 1 ng/mL) are independently associated with a modest but significant reduction in the chance of natural conception — but the effect is modest, not absolute. Many patients with low AMH conceive successfully, particularly with IVF.
FSH and Estradiol
Why these two are always read together
FSH is measured in milli-international units per milliliter (mIU/mL). Unlike AMH, which stays stable throughout your cycle, FSH is drawn specifically on day 2 or 3 because that's when it should be at its lowest baseline level.
| Day 3 FSH level | General interpretation |
|---|---|
| Below 10 mIU/mL | Normal — Reassuring ovarian reserve signal. Good IVF prognosis. |
| 10 – 15 mIU/mL | Borderline elevated — Reduced reserve likely. A study on day 3 FSH and IVF outcomes showed that patients with day 3 FSH below 15 mIU/mL had a better chance of becoming pregnant with IVF compared to those with FSH between 15 and 24.9 mIU/mL. |
| Above 15 mIU/mL | Elevated — Significant reserve concern. A high FSH level above 10 IU/mL is generally associated with diminished ovarian reserve. IVF outcome less predictable; individualized protocol required. |
Why estradiol matters here: If FSH is normal but estradiol level is elevated, the elevated estradiol will often artificially suppress FSH down to the normal range. This is why your RE looks at both together. At baseline (day 2 or 3), estradiol should be relatively low — usually under 50–60 pg/mL. If the baseline estradiol level is elevated, it may suggest a residual cyst from a previous cycle or indicate lower ovarian reserve.
A prospective study of 292 IVF cycles found that patients who presented with an elevated day 3 E2 (≥80 pg/mL) had a higher cancellation rate and achieved a lower pregnancy rate, independent of FSH level. This is why a "normal" FSH result isn't always reassuring on its own.
Antral follicle count
The ultrasound number that drives your IVF protocol
AFC is counted during a transvaginal ultrasound, typically on the same day as your bloodwork. Your doctor counts all visible follicles between 2–9mm across both ovaries. The total is one of the strongest predictors of how your ovaries will respond to stimulation medications.
| Total AFC | Response prediction | What this typically means |
|---|---|---|
| 15 or above | Excellent | High egg retrieval expected. OHSS risk monitoring needed. Strong IVF candidate. |
| 10 – 14 | Good | Normal ovarian reserve. Good response to stimulation anticipated. |
| 6 – 9 | Moderate | Adequate reserve. May need higher medication doses to achieve optimal response. IVF still often successful. |
| Below 6 | Low | A low AFC (below 5 follicles) indicates lower ovarian reserve and a lower chance of success with IVF treatment. Protocol adjusted accordingly. Quality of eggs retrieved may still be high. |
| 22 or above | Very high — possible PCOS | A high AFC of 16–24 total follicles suggests excellent ovarian reserve but may increase the risk of OHSS. Protocol adjusted to reduce that risk. |
One important caveat: AFC is not perfect. Ultrasound interpretation can vary slightly among clinicians, and IVF success depends on many factors beyond follicle count, including age, egg quality, sperm quality, embryo development, and uterine health.
What the numbers miss
Five things your bloodwork results don't tell you
Results can be reassuring or alarming, but they're always incomplete. Here's what they can't measure — and why that matters.
Egg quality
The single most important fertility factor — and the least measurable
AMH, FSH, and AFC all measure egg quantity — how many follicles are present. None of them measures egg quality, which is the primary driver of whether an embryo is chromosomally normal and capable of implanting.
Age is the most reliable predictor of egg quality. A 32-year-old with a low AMH has better egg quality prospects than a 42-year-old with a normal AMH. Your RE weighs this heavily when interpreting your results.
Your chance of natural pregnancy
These tests were designed for IVF planning, not natural conception prediction
Ovarian reserve tests were developed to predict response to stimulation medications in an IVF context — not to predict natural fertility. A low AMH does not mean you cannot conceive naturally. Many women with "poor reserve" on paper conceive without assistance, particularly when younger.
Conversely, a reassuring AMH result doesn't guarantee pregnancy — it only indicates egg quantity. Other factors like tubal health, uterine anatomy, sperm quality, and ovulation regularity all play significant roles that bloodwork doesn't capture.
Sperm factors
Up to half of infertility involves sperm — a semen analysis is essential
Female bloodwork tells only half the story. Male factor infertility is involved in approximately 40–50% of cases. If a semen analysis hasn't been ordered yet, it should be — the results significantly shape which treatment path makes the most sense. See our guide to IUI vs. IVF for how sperm results typically influence that decision.
Uterine and tubal health
Ovarian reserve tests say nothing about implantation conditions
Bloodwork and AFC don't assess the uterine lining, the shape of the uterine cavity, or whether the fallopian tubes are open. A hysterosalpingogram (HSG) is typically ordered separately to check tubal patency and uterine anatomy. Conditions like fibroids, polyps, or adhesions — which can significantly affect implantation — are invisible to a hormone panel.
How you'll actually respond to treatment
Stimulation response is partly predictable, partly not
AFC and AMH give your RE a strong starting point for estimating medication dose and expected egg retrieval — but individual response varies. Some patients with a low AFC retrieve more eggs than expected; others with a high AFC respond poorly. The first cycle is, in part, diagnostic. Your RE uses that response data to refine protocols for any subsequent cycles. This is why understanding your medications and the monitoring process that follows matters so much.
What comes next
From results to a treatment plan
Once your RE has your full panel — AMH, FSH, estradiol, and AFC together — they'll use those results to recommend a treatment path and, if moving toward IVF, to determine your medication protocol: which drugs, at what dose, for how long.
If you're heading toward IVF, the protocol your RE writes goes directly to your pharmacy. That's where Prima comes in — we receive the prescription from your clinic, verify your insurance within 24 hours, apply manufacturer savings programs automatically, and ship your medications with temperature-controlled packaging. For a full walkthrough of that process, see what to expect after your first fertility appointment.
If you want to understand your results in the context of your lifestyle before making any decisions, Prima partners with a registered dietitian specializing in fertility nutrition, at-home hormone tracking, and therapists who specialize in fertility — because getting to a healthy baseline matters.
Tests before IVF
What gets ordered and why
IUI vs. IVF
How results shape the decision
Medications 101
Every fertility drug, explained
Fertility insurance coverage
What's typically covered and what's not
Request a free price quote
Know your medication costs before you commit
Financing your medications
Savings programs, discounts, and lending
Your results are a starting point, not a verdict. Whatever the numbers say, the next step is a conversation with your RE — and Prima is here for everything that follows that conversation.
Ready to get started with Prima?
Call or text us: (718) 230-3535 — open 7 days a week
Clinical Note
The reference ranges and clinical interpretations in this post are drawn from published fertility research and clinical guidelines current as of 2025–2026, including sources from Cleveland Clinic, PubMed, and leading reproductive endocrinology centers. Reference ranges vary between laboratory platforms — always interpret your results against your own lab's reference values and in consultation with your reproductive endocrinologist. This content is educational and does not constitute medical advice.
